GPX4 and neoplasm: Therefore, Ma et al. [288] implemented a dual-targeted intervention strategy: 1) they modulated tumor lipid metabolism by concurrently suppressing GPX4 and FSP1, thereby amplifying LPO and potentiating ICD; and 2) they reprogrammed immune lipid metabolism to alleviate immunosuppressive constraints.